Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Non-Current Deffered Revenue (2019 - 2021)

Strata Critical Medical (SRTA) has disclosed Non-Current Deffered Revenue for 3 consecutive years, with $9.6 million as the latest value for Q1 2021.

  • Quarterly Non-Current Deffered Revenue changed 0.0% to $9.6 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $9.6 million through Mar 2021, changed 0.0% year-over-year, with the annual reading at $9.6 million for FY2020, N/A changed from the prior year.
  • Non-Current Deffered Revenue for Q1 2021 was $9.6 million at Strata Critical Medical, roughly flat from $9.6 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $9.6 million in Q3 2019, with the low at $9.6 million in Q3 2019.
  • Average Non-Current Deffered Revenue over 3 years is $9.6 million, with a median of $9.6 million recorded in 2019.
  • Peak annual rise in Non-Current Deffered Revenue hit 0.0% in 2020, while the deepest fall reached 0.0% in 2020.
  • Over 3 years, Non-Current Deffered Revenue stood at $9.6 million in 2019, then changed by 0.0% to $9.6 million in 2020, then changed by 0.0% to $9.6 million in 2021.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $9.6 million, $9.6 million, and $9.6 million for Q1 2021, Q4 2020, and Q3 2020 respectively.